Abstract: The present invention pertains to a saturated furodioxin derivative compound, and a use thereof as an additive for a secondary battery. More specifically, the present invention pertains to a novel compound and a method for preparing same, an electrolyte additive and a non-aqueous electrolyte composition containing the compound, and a secondary battery (in particular, a lithium-sulfur secondary battery) including the electrolyte composition, wherein the compound has a structure in which a substituent is bonded to a saturated furodioxin backbone. When the compound is contained as an additive in a non-aqueous electrolyte composition for a secondary battery (in a non-aqueous electrolyte composition for a lithium-sulfur secondary battery), the problem that conventional electrolyte compositions have of lithium polysulfide dissolution can be resolved, and high capacity retention rate characteristics can be achieved for various lithium salts.

Abstract: According to one aspect of the present invention, a group account service providing server capable of converting a private account into a group account in real time through a terminal of the host of a comprises: an account management unit configured to convert a first account into a group account when a group account conversion request for the first account of a host of a group is generated; a transaction ledger management unit configured to record change information in a transaction ledger for the group account when the change information including at least one of a transaction occurrence event and an information occurrence event is generated for the group account; a virtual ledger management unit configured to generate a virtual ledger to be mapped to the transaction ledger when the first account is changed to the group account.

Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: According to one aspect of the present invention, a group account service providing server capable of converting a private account into a group account in real time through a terminal of the host of a comprises: an account management unit configured to convert a first account into a group account when a group account conversion request for the first account of a host of a group is generated; a transaction ledger management unit configured to record change information in a transaction ledger for the group account when the change information including at least one of a transaction occurrence event and an information occurrence event is generated for the group account; a virtual ledger management unit configured to generate a virtual ledger to be mapped to the transaction ledger when the first account is changed to the group account.

Abstract: A method of displaying an application is provided. The method includes displaying an execution screen of a first application on a first area when the first application is executed, displaying the execution screen of the first application on a second area instead of on the first area when a second application is executed while the first application is executed, and displaying an execution screen of a second application on the first area.

Abstract: An anode for a secondary battery includes an anode current collector, and an anode active material layer including a first anode active material layer and a second anode active material layer sequentially stacked from a surface of the anode current collector. Each of the first anode active material layer and the second anode active material layer includes a carbon-based active material and a silicon-based active material as an anode active material, and a carbon nanotube as a conductive material. A content of the silicon-based active material in the second anode active material layer is greater than a content of the silicon-based active material in the first anode active material layer. A Raman R value of the carbon nanotube included in the second anode active material layer is smaller than a Raman R value of the carbon nanotube included in the first anode active material layer.

Abstract: Embodiments of the present invention provide a lithium secondary battery including anode active material layers which have a multi-layered structure and include carbon-based active materials having different contents from each other, thereby improving mechanical stability and battery performance.

Abstract: The present invention relates to a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative, and a pharmaceutical composition for preventing or treating cancer comprising the compound as an effective component. The compound exhibits high inhibitory activity against an epidermal growth factor receptor (EGFR) variant, or wild-type or variants of one or more of ERBB2 and ERBB4, and thus may be usefully used in the treatment of cancers in which same are expressed. In particular, the compound exhibits excellent inhibitory activity on proliferation of lung cancer cell lines, and thus can be usefully used in the treatment of lung cancer.

Abstract: Disclosed is a rail locking device in a rail structure having a mounting area provided in a first rail or a second rail. The first and second rails are coupled to each other and the first rail may slide along the second rail. In particular, the rail locking device includes a moving cover portion mounted in the mounting area, and a locking portion having wound therein the moving cover portion extending from the mounting area and configured to selectively limit extraction of the moving cover portion to temporarily fix the first rail that slides forwards or rearwards of the second rail in place.

Abstract: The present invention relates to a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative, and a pharmaceutical composition for preventing or treating cancer comprising the compound as an effective component. The compound exhibits high inhibitory activity against an epidermal growth factor receptor (EGFR) variant, or wild-type or variants of one or more of ERBB2 and ERBB4, and thus may be usefully used in the treatment of cancers in which same are expressed. In particular, the compound exhibits excellent inhibitory activity on proliferation of lung cancer cell lines, and thus can be usefully used in the treatment of lung cancer.

Abstract: The present disclosure provides a substituted piperidine compound of Chemical Formula 1, or a pharmaceutically acceptable salt thereof having activity of degrading androgen receptor (AR). The present disclosure also provides a composition comprising such a substituted piperidine compound or a pharmaceutically acceptable salt thereof. The present disclosure also provides a medical use of a substituted piperidine compound according to the present disclosure, a salt thereof, and a composition comprising the same for the treatment or prophylaxis of AR-related diseases. The present disclosure also provides a method for treating or preventing an AR-related disease comprising administering to a subject in need thereof an effective amount of a substituted piperidine compound according to the present disclosure, a salt thereof, or a composition comprising the same.

Abstract: An image sensor including a variable resistance element is provided. The image sensor comprises first and second chips having first and second connecting structures; and a contact plug connecting the first and second chips. The first chip includes a photoelectric conversion element. The second chip includes a first variable resistance element. The contact plug extends from the first surface of the first semiconductor substrate to connect the first and second connecting structures.

Abstract: The present disclosure is a housing stacking energy storage system. In the present disclosure, a first housing 10 and a second housing 20 having a predetermined size are stacked, and a rack 30 is installed in a first inner space 11 of the first housing 10 and a second inner space 21 of the second housing 20 to mount a plurality of battery packs 32. The first inner space 11 and the second inner space 21 communicate with each other to form one space, and a control unit 46, a fire extinguishing system 47 and a spray system 48 are installed therein. According to the present disclosure, it is possible to firmly install the energy storage system having a relatively large capacity in a specific installation area.

Abstract: A bearing device for a vehicle includes a main body unit mounted on a mounting region in a rail structure configured so that the mounting region is formed on a first rail that is any one of two rails rail-coupled to slide and the first rail slides along a second rail, a first shape unit provided to protrude from an upper surface of the main body unit and be in contact with the second rail and formed to damp a vibration in a first direction transmitted to the main body unit, and a second shape unit provided to protrude from a side surface of the main body unit and be in contact with the second rail and formed to damp a vibration in a second direction transmitted to the main body unit.

Abstract: A display panel includes: a base substrate; a thin film transistor layer on the base substrate and including: a lower metal layer configured to receive a low potential voltage; a pixel circuit including at least one transistor; and a sensor circuit electrically connected to the lower metal layer; and an element layer on the thin film transistor layer having a light emitting element including: a first pixel electrode electrically connected to the pixel circuit; a second pixel electrode configured to receive the low potential voltage; and a light receiving element electrically connected to the sensor circuit and configured to receive the low potential voltage from the lower metal layer.

Abstract: The present invention relates to a slurry for fabricating an electrode, an electrode, and an electrochemical cell including same. The slurry for fabricating an electrode according to the present invention includes: an electrode material; an organic binder; and two or more solvents having different solubility parameters. The electrode fabricated using the slurry for fabricating an electrode according to the present invention may have a structure in which electrode materials are dispersed and bound to a porous matrix in a network configuration.

Abstract: The present disclosure provides a substituted piperidine compound of Chemical Formula 1, wherein X is CR3, or a pharmaceutically acceptable salt thereof having activity of degrading androgen receptor (AR). The present disclosure also provides a composition comprising such a substituted piperidine compound or a pharmaceutically acceptable salt thereof. The present disclosure also provides a medical use of a substituted piperidine compound according to the present disclosure, a salt thereof, and a composition comprising the same for the treatment or prophylaxis of AR-related diseases. The present disclosure also provides a method for treating or preventing an AR-related disease comprising administering to a subject in need thereof an effective amount of a substituted piperidine compound according to the present disclosure, a salt thereof, or a composition comprising the same.

Abstract: The present invention relates to a cytokine trimer domain in which a first monomer and a second monomer linked by linker (dimer) and a third monomer are coupled by a knob-into-hole and a novel type of fusion protein in which antibody and cytokine trimer domains are linked (receptor-antibody conjugated (cell) engager, RACE) prepared by replacing a constant region (Fc) of an antibody with the cytokine trimer domain, and RACE according to the present invention exhibits superior binding ability to the target receptor than the parent antibody as well as excellent simultaneous binding ability to the antigen and the target receptor, which can be usefully utilized as a bispecific pharmaceutical composition.

Abstract: A bidirectionally openable console includes side lid portions, a center lid portion positioned between the side lid portions, a first button unit positioned at a front end of the center lid portion, a second button unit positioned at a rear end of the center lid portion, and rotary units configured to be respectively rotated by movement of the first and second button units. The console further includes: fastening units, each of which is constructed such that, when an opening request input is applied to a corresponding button unit, a corresponding rotary unit is rotated to retract a central shaft portion into the center lid portion; hinge units, each of which is rotated together with the center lid portion when the center lid portion is opened, and locking units, each of which restricts movement of the fastening unit when the center lid portion is closed.

Abstract: A method of displaying an application is provided. The method includes displaying an execution screen of a first application on a first area when the first application is executed, displaying the execution screen of the first application on a second area instead of on the first area when a second application is executed while the first application is executed, and displaying an execution screen of a second application on the first area.